Redcare Pharmacy N.V.
SHPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,370,575 | $1,798,758 | $1,204,352 | $1,060,321 |
| % Growth | 31.8% | 49.4% | 13.6% | – |
| Cost of Goods Sold | $1,824,796 | $1,358,375 | $872,566 | $793,793 |
| Gross Profit | $545,779 | $440,383 | $331,786 | $266,528 |
| % Margin | 23% | 24.5% | 27.5% | 25.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $41,482 | $32,998 | $26,511 | $21,250 |
| SG&A Expenses | $356,649 | $267,437 | $244,239 | $196,884 |
| Sales & Mktg Exp. | $315,167 | $234,439 | $217,728 | $175,634 |
| Other Operating Expenses | $228,117 | $190,241 | $0 | $0 |
| Operating Expenses | $584,766 | $457,678 | $401,107 | $332,386 |
| Operating Income | -$38,987 | -$17,295 | -$69,172 | -$65,698 |
| % Margin | -1.6% | -1% | -5.7% | -6.2% |
| Other Income/Exp. Net | -$8,846 | $2,947 | -$14,947 | -$12,186 |
| Pre-Tax Income | -$47,833 | -$14,348 | -$84,119 | -$77,884 |
| Tax Expense | -$1,477 | -$2,742 | -$6,473 | -$3,699 |
| Net Income | -$45,464 | -$12,041 | -$77,646 | -$74,185 |
| % Margin | -1.9% | -0.7% | -6.4% | -7% |
| EPS | -2.26 | -0.63 | -4.32 | -4.15 |
| % Growth | -258.7% | 85.4% | -4.1% | – |
| EPS Diluted | -2.26 | -0.63 | -4.32 | -4.15 |
| Weighted Avg Shares Out | 20,118 | 19,239 | 17,985 | 17,883 |
| Weighted Avg Shares Out Dil | 20,118 | 19,239 | 17,985 | 17,883 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,403 | $4,605 | $274 | $28 |
| Interest Expense | $7,775 | $7,998 | $8,504 | $8,566 |
| Depreciation & Amortization | $68,217 | $57,288 | $39,510 | $26,964 |
| EBITDA | $28,159 | $50,938 | -$36,105 | -$42,354 |
| % Margin | 1.2% | 2.8% | -3% | -4% |